logo

FBT

First Trust NYSE Arca Biotechnology Index Fund·ARCA
--
--(--)
--
--(--)

Key Stats

Assets Under Management
2.19BUSD
Fund Flow (1Y)
1.08BUSD
Dividend Yield
0.61%
Discount / Premium to NAV
-0.07%
Shares Outstanding
11.40M
Expense Ratio
0.54%

About First Trust NYSE Arca Biotechnology Index Fund

Issuer
First Trust Advisors L.P.
Brand
First Trust
Inception Date
Jun 19, 2006
Structure
Open-Ended Fund
Index Tracked
NYSE Arca Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the fund's broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBT's equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.

Classification

Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting Scheme
Equal
Selection Criteria
Market cap

Analysis

Holdings

Symbol

Ratio

logo

MRNA

Moderna
5.56%
logo

GILD

Gilead Sciences
4.22%
logo

UTHR

United Therapeutics
4.01%
logo

AMGN

Amgen
3.99%
logo

EXAS

Exact Sciences
3.82%

Symbol

Ratio

logo

BIIB

Biogen
3.64%
logo

VRTX

Vertex Pharmaceuticals
3.62%
logo

KRYS

Krystal Biotech
3.56%
logo

EXEL

Exelixis
3.50%
logo

NBIX

Neurocrine Biosciences
3.48%

Top 10 Weight 39.4%

31 Total Holding

See all holdings

Related Funds

Seasonals

Volume Profile

Trade Flow Insight

Community

Loading...

Related News

No articles available

You can ask Aime

No Data